EN 中文
Home Strategic Partnerships News Contact us
TOTAL:36 NEWS
First Patient Enrolled for the Phase III Clinical Trial of Zhaoke Ophthalmology’s Myopia Drug, NVK002
read
2022-03-23
158
Zhaoke Ophthalmology Establishes Strategic Partnerships with Sinopharm Distribution Centre, Shanghai Pharmaceuticals, and CR Pharmaceutical Commercial
read
2022-03-08
315
Zhaoke Ophthalmology Supports Research at Johns Hopkins University’s Wilmer Eye Institute
read
2022-02-16
216
Last Patient Enrolled for the Phase II Clinical Trial of Zhaoke Ophthalmology’s ZKY001, for the Treatment of Corneal Epithelial Defects
read
2022-01-26
277
Zhaoke Ophthalmology Received the “Most Valuable Pharmaceutical and Medical Company” Award From Zhitong Finance’s Sixth Golden Hong Kong Stocks Award
read
2022-01-13
408
>
Guangzhou Headquarters
Tel: 020-39062888
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat
Guangzhou Headquarters
Tel: 020-39062888
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat